Exelixis
EXEL
#1557
Rank
$14.13 B
Marketcap
$56.22
Share price
1.24%
Change (1 day)
27.02%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company